Elos Medtech Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Elos Medtech
Access all reports
Elos Medtech is the leading global developer and manufacturer of dental implants, components for implant-borne prosthetics and instruments for the dental implant market. It offers dental implants and surgical instruments, orthopedic implants, components and instruments, bone cement, dental bone substitute materials, and laboratory tools. The company also provides research services in various areas of product development; development of customising existing equipment to meet specific user requirements; research into new materials used in the construction of devices; and research on new methods of coating implants with bioactive substances to promote the formation of a stable connection between implant surface and surrounding bone.
Latest articles
)
Figma: Collaborative Design Tool Ready for IPO
Figma, the popular design platform, is preparing for a potential IPO in 2025 as it continues to reshape the future of collaborative design.
22 May 2025
)
Companies That Had Their IPO in 2024: Momentum Increasing
2024 marked a steady year for IPOs, driven by strong markets, AI momentum, and high-profile listings across industries and regions.
22 May 2025
)
The Rise and Fall of Wirecard
A look inside the Wirecard scandal, which took the company from the prestigious DAX 30 to insolvency through the largest accounting fraud in European history.
16 May 2025
Ticker symbol
ELOS
Country
🇸🇪 Sweden